Dan J Mitchell is listed as a director on 8 SEC Form D filings by 2 issuers between Mar 2009 and Jun 2015: ARCA biopharma, Inc. (Westminster, CO — pharmaceuticals — 2015; $51.7M reported sold to 14 investors) and GLOBEIMMUNE INC (Louisville, CO — pharmaceuticals — 2009–2014; $18M reported sold to 110 investors).
What this means 2 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $69.6M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 court cases matching the name, 5 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for Dan J Mitchell and found 5 differences, 2 worth asking the sponsor about: Investor count went down between filings; Form D filed 120 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.